Angelo Raffaele Bianco
- Oncology top 1%
- HER2/EGFR in Cancer Research 25
- Cancer Treatment and Pharmacology 14
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 8
- Cancer Research top 2%
- Breast Cancer Treatment Studies 7
-
- Lung Cancer Treatments and Mutations 9
- Genetics top 5%
- Estrogen and related hormone effects 7
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Fortunato CiardielloSabino De PlacidoGiampaolo TortoraMichelino De LaurentiisRoberto BiancoStefano PepeJohn MendelsohnGabriella Fontanini
- Journals
- New England Journal of Medicine (1 paper)The Lancet (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Angelo Raffaele Bianco
96 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 109
- Oncology 2.6k
- Cancer Research 860
- Pulmonary and Respiratory Medicine 987
- Pathology and Forensic Medicine 413
- Genetics 574
Countries citing papers authored by Angelo Raffaele Bianco
This map shows the geographic impact of Angelo Raffaele Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Raffaele Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Raffaele Bianco more than expected).
Fields of papers citing papers by Angelo Raffaele Bianco
This network shows the impact of papers produced by Angelo Raffaele Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Raffaele Bianco. The network helps show where Angelo Raffaele Bianco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angelo Raffaele Bianco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 66 | |
| 2 | Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 2003 | 101 |
| 3 | 2002 | 7 | |
| 4 | 2002 | 12 | |
| 5 | 2002 | 2 | |
| 6 | 2000 | 11 | |
| 7 | 1999 | 141 | |
| 8 | 1998 | 111 | |
| 9 | 1997 | 91 | |
| 10 | 1997 | 76 | |
| 11 | 1996 | 93 | |
| 12 | 1995 | 156 | |
| 13 | 1994 | 5 | |
| 14 | 1994 | 8 | |
| 15 | 1994 | 19 | |
| 16 | 1994 | 27 | |
| 17 | 1992 | 59 | |
| 18 | 1992 | 6 | |
| 19 | 1990 | 24 | |
| 20 | 1989 | 30 |
About Angelo Raffaele Bianco
Angelo Raffaele Bianco is a scholar working on Oncology, Cancer Research and Reproductive Medicine, having authored 100 papers that have together received 4.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (25 papers), Cancer Treatment and Pharmacology (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Estrogen and related hormone effects (7 papers) and Breast Cancer Treatment Studies (7 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (860 citations) and Pulmonary and Respiratory Medicine (987 citations). Angelo Raffaele Bianco has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Fortunato Ciardiello, Sabino De Placido, Giampaolo Tortora, Michelino De Laurentiis, Roberto Bianco, Stefano Pepe, John Mendelsohn, Gabriella Fontanini, Vincenzo Damiano and V. Damiano. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.